-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
TNF Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2023.
- TNF Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$9.57M, a 130% decline year-over-year.
- TNF Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$17.7M, a 34.8% decline year-over-year.
- TNF Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4M, a 73.7% increase from 2022.
- TNF Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$15.2M, a 49.2% increase from 2021.
- TNF Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$29.9M, a 215% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)